The importance of transcutaneous oxygen tension monitoring in diabetic patient with complications

Czech version

Authors: David Baláž; Andrea Komorníková; Peter Sabaka; Ľudovít Gašpar; Andrej Dukát
Authors‘ workplace: II. interná klinika LF UK a UN Bratislava, Slovenská republika, prednosta doc. MUDr. Ľudovít Gašpar, CSc.
Published in: Vnitř Lék 2015; 61(2): 106-113
Category: Review

Overview

Monitoring of transcutaneous perfusion pressure of tissue oxygen (tcpO₂) is a simple, non-invasive method performed in diagnostic process of chronic diabetic complications. Primary, tcpO₂ is used as an indicator of microcirculatory function. Properly placed and fixed Clark electrode is able to detect with high accuracy partial oxygen pressure on the skin surface by polarographic system of dissolved oxygen from capillary bed through tissues to upper layers of the skin. The microcirculation function is influenced by macrocirculation, thus, tcpO₂ is a suitable parameter in diagnosis of peripheral arterial obliterative disease or other vascular pathologies. Combination of tcpO₂ monitoring and skin perfusion pressure by laser Doppler technique gives us information not only about nutritive capillary flow, but also about vessels which precede capillary bed. The article discusses current guidelines for measurement of tcpO₂and evaluation of the results. Also reviews the results of recent studies which are interested in the use of tcpO₂in diabetic patients.

Key words:
diabetic foot ulcer – diabetic microangiopathy – diabetic neuropathy – peripheral arterial obliterative disease – transcutaneous oxygen tension monitoring

Sources

1. Apelqvist J. Diagnostics and treatment of the diabetic foot. Endocrine 2012; 41(3): 384–397.

2. Gašpar L.Transkutánna oxymetria – použitie v diagnostike syndrómu diabetickej nohy. In: Krahulec B, Gašpar L, Štvrtinová V et al. Manažment pacienta so syndrómom diabetickej nohy. Veda: Bratislava 2013: 141–156. ISBN 978–80–224–1293–3.

3. International Working Group on the Diabetic Foot. International consensus on the diabetic foot and practical guidelines on the management and the prevention of the diabetic foot. Amsterdam 2011. Dostupné z WWW: http://www.idf.org/bookshop nebo http://www.diabeticfoot.nl.

4. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005; 293(2): 217–228.

5. Hauser CJ, Appel P, Shoemaker WC. Pathophysiologic classification of peripheral vascular disease by positional changes in regional transcutaneous oxygen tension. Surgery 1984; 95(6): 689–693.

6. Shah JB, Ram DM, Fredrick E et al. Determination of ideal PtcO2 measurement time in evaluation of hypoxic wound patients. Undersea Hyperb Med 2008; 35(1): 41–51.

7. Fife CE, Smart DE, Sheffield PJ et al. Transcutaneous Oximetry in Clinical Practice: Consensus statements from an expert panel based on evidence. Undersea Hyperb Med 2009; 36(1): 43–53.

8. Prompers L, Huijberts M, Apelqvist J et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 2007; 50(1): 18–25.

9. Brownrigg JRW, Apelqvist J, Bakker K et al. Evidence-based Management of PAD & the Diabetic Foot. Eur J Vasc Endovasc Surg 2013; 45(6): 673–681.

10. Apelqvist J, Bakker K, van Houtum WH et al. International Working Group on the Diabetic Foot (IWGDF) Editorial Board. Practical guidelines on the management and prevention of the diabetic foot : Based upon the International Consensus on the Diabetic Foot (2007) Prepared by the International Working Group on the Diabetic Foot. Diabetes Metab Res Rev 2008; 24(Suppl 1): S181-S187.

11. Norgren L, Hiatt WR, Dormandy JA et al. TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007; 33(Suppl 1): S1-S75.

12. Urbanova R, Jirkovska A, Woskova V et al. Transcutaneous oximetry in the diagnosis of ischemic disease of the lower extremities in diabetics. Vnitř Lék 2001; 47(5): 330–332.

13. Potier L, Abi Khalil C, Mohammedi K et al. Use and utility of ankle brachial index in patients with diabetes. Eur J Vasc Endovasc Surg 2011; 41(1): 110–116.

14. Arsenault KA, McDonald J, Devereaux PJ et al. The use of transcutaneous oximetry to predict complications of chronic wound healing: a systematic review and meta-analysis. Wound Repair Regen 2011; 19(6): 657–663.

15. Orchard TJ, Strandness DE. Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association September 18–20, 1992 New Orleans, Louisiana. Circulation 1993; 88(2): 819–828.

16. Rajagopalan S, Mukherjee D, Mohler ER. Manual of vascular diseases. Lippincott Williams and Wilkins 2005. 2: 16. ISBN 978–0781744997.

17. Park SC, Choi CY, Ha YI et al. Utility of Toe-brachial Index for Diagnosis of Peripheral Artery Disease. Arch Plast Surg 2012; 39(3): 227–231.

18. Hyun S, Forbang NI, Allison MA et al. Ankle-brachial index, toe-brachial index, and cardiovascular mortality in persons with and without diabetes mellitus. J Vasc Surg 2014; 60(2): 390–395.

19. Hoyer C, Sandermann J, Petersen LJ. The toe-brachial index in the diagnosis of peripheral arterial disease. J Vasc Surg 2013; 58(1): 231–238.

20. Carter SA, Tate RB. The value of toe pulse waves in determination of risks for limb amputation and death in patients with peripheral arterial disease and skin ulcers or gangrene. J Vasc Surg 2001; 33(4): 708–714.

21. Anderson CA. Noninvasive assessment of lower extremity hemodynamics in individuals with diabetes mellitus. J Vasc Surg 2010; 52(3 Suppl): 76S-S80. Dostupné z DOI: <http://doi: 10.1016/j.jvs.2010.06.012>.

22. Pardo M, Alcaraz M, Bernal FL. A solution to ankle-brachial index limitations in peripheral transluminal angioplasty. Radiol Med 2013; 118(8): 1373–1378.

23. Pola P, Tondi P, Dal Lago A et al. Transcutaneous oximetry is useful in vascular pathology if a cutaneous reference map and a maximal exercise test are used. Vasc Endovas Surg 1996; 30: 117–122.

24. Wipke-Tevis DD, Stotts NA, Williams DA et al. Tissue oxygenation, perfusion, and position in patients with venous leg ulcers. Nurs Res 2001; 50(1): 24–32.

25. Wyss CR, Matsen FA, Simmons CW et al. Transcutaneous oxygen measurements on limbs of diabetic and non-diabetic patients with peripheral vascular disease. Surgery 1984; 95(3): 339–345.

26. Padberg FT, Back TL, Thompson PN et al. Transcutaneous oxygen (TcPO2) estimates probability of healing in the ischaemic extremity. J Surg Res 1996; 60(2): 365–369.

27. White RA, Nolan L, Harley D et al. Noninvasive evaluation of peripheral vascular disease using transcutaneous oxygen tension. Am J Surg 1982; 144(1): 68–75.

28. Grolman RE, Wilkerson DK, Taylor J et al. Transcutaneous oxygen measurements predict a beneﬁcial response to hyperbaric oxygen therapy in patients with non-healingwounds and critical limb ischaemia. Am Surg 2001; 67(11): 1072–1080.

29. Poredos P, Rakovec S, Guzic-Salobir B. Determination of amputation level in ischaemic limbs using tcPO2 measurement. Vasa 2005; 34(2): 108–112.

30. Rooke T. TcpO2 in non-invasive vascular medicine. Blood Gas News 1998; 7(2): 21–23.

31. Becker F, Raoux MH, Brenot R et al. Predictive value of tcpO2 in chronic severe ischemia of lower limbs. Int J Microcir Clin Exp 1988; 7: 261–271.

32. Osmundson PJ, Rooke TW, Hallett JW. Effect of arterial revascularization on transcutaneous oxygen tension of the ischemic extremity. Mayo Clin Proc 1988; 63(9): 897–902.

33. Arroyo CI, Tritto VG, Buchbinder D et al. Optimal waiting period for foot salvage surgery following limb revascularization. Foot Ankle Surg 2002; 41(4): 228–232.

34. Caselli A, Latini V, Lapenna A et al. Transcutaneous oxygen tension monitoring after successful revascularization in diabetic patients with ischaemic foot ulcers. Diabet Med 2005; 22(4): 460–465.

35. Benhamou Y, Edet S, Begarin L et al. Transcutaneous oxymetry as predictive test of peripheral vascular revascularization in haemodialysis population. Nephrol Dial Transplant 2012; 27(5): 2066–2069.

36. Castronuovo JJ, Adera HM, Smiell JM et al. Skin perfusion pressure measurement is valuable in the diagnosis of critical limb ischemia. J Vasc Surg 1997; 26(4): 629–637.

37. Dietz DA, Shefﬁeld PJ. Non-invasive wound assessment tools. In: Shefﬁeld PJ, Fife CE (eds). Wound Care Practice.2nd ed. Best Publishing Company: Flagstaff, AZ 2007: 129–174. ISBN 978–1930536388.

38. Tomesova J, Gruberova J, Broz P et al. Methods of skin microcirculation assessment. Vnitř Lék 2013; 59(10): 895–902.

39. Castronuovo JJ The role of skin perfusion pressure and transcutaneous partial pressure oxygen measurements in chronic critical limb ischemia. In: Mansour MA, Labropoulos N (eds) Vascular Diagnosis. Saunders: New York 2004: 247–255. ISBN 978–0721694269.

40. Takkin L, Sample R, Moore P et al. Prediction of Wound Healing Outcome Using Skin Perfusion Pressure & Transcutaneous Oximetry. Wounds 2009; 21(11): 310–316.

41. Dubsky M, Jirkovska A, Bem R et al. Treatment of critical limb ischemia and diabetic foot disease by the use of autologous stem cells. Vnitř Lék 2011; 57(5): 451–455.

42. Cechurova D, Rusavy Z, Lacigova S et al. Transcutaneous oxygen tension in hyperbariccondition as a predictor of ischaemia in non-healing diabetic foot ulcers. Vnitř Lék 2002; 48(10): 971–975.

43. Dowd G. Predicting stump healing following amputation for peripheral vascular disease using the transcutaneous oxygen monitor. Ann R Coll Surg Engl 1987; 69(1): 31–35.

44. Arsenault KA, Al-Otaibi A, Devereaux PJ et al. The use of transcutaneous oximetry to predict healing complications of lower limb amputations: A systematic review and meta-analysis. Eur J Vasc Endovasc Surg. 2012; 43(3): 329–336.

45. Christiansen KS, Klarke M. Transcutaneous oxygen measurement in peripheral occlusive disease. An indicator of wound healing in leg amputation. J Bone Joint Surg Br 1986; 68(3): 423–426.

46. Wütschert R, Bounameaux H. Determination of Amputation Level in Ischemic Limbs: Reappraisal of the measurement of TcPO2. Diabetes Care 1997; 20(8): 1315–1318.

47. Setacci C, Ricco JB. European Society for Vascular Surgery. Guidelines for critical limb ischaemia and diabetic foot--introduction. Eur J Vasc Endovasc Surg. 2011; 42(Suppl 2):S1-S3.

48. Caputo GM, Cavanagh PR, Ulbrecht JS et al. Assessment and management of foot disease in patients with diabetes. N Engl J Med 1994; 331(13): 854–860.

49. Prompers L, Schaper N, Apelqvist J et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study. Diabetologia 2008; 51(5): 747–755.

50. Raman R, Gupta A, Krishna S et al. Prevalence and risk factors for diabetic microvascular complications in newly diagnosed type II diabetes mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 27). J Diabetes Complications 2012; 26(2): 123–128.

51. Schaper NC, Huijberts M, Pickwell K. Neurovascular control and neurogenic inﬂammation in diabetes. Diabetes Metab Res Rev 2008; 24(Suppl 1): S40-S44.

52. Sun PC, Kuo CD, Chi LY et al. Microcirculatory vasomotor changes are associated with severity of peripheral neuropathy in patients with type 2 diabetes. Diab Vasc Dis Res 2013; 10(3): 270–276.

53. De Meijer VE, Van’t Sant HP, Spronk S et al. Reference value of transcutaneous oxygen measurement in diabetic patients compared with nondiabetic patients. J Vasc Surg 2008; 48(2): 382–388.

54. Chao CY, Zheng YP, Cheing GL The association between skin blood ﬂow and edema on epidermal thickness in the diabetic foot. Diabetes Technol Ther 2012; 14(7): 602–609.

55. Deng W, Dong X, Zhang Y et al. Transcutaneous oxygen pressure (TcPO₂): a novel diagnostic tool for peripheral neuropathy in type 2 diabetes patients. Diabetes Res Clin Pract 2014; 105(3):336–343.

56. Kyle AA, McDonald J, Devereaux PJ et al. The use of transcutaneous oximetry to predict complications of chronic wound healing: A systematic review and meta-analysis. Wound Repair Regen 2011; 19(6): 657–663.

57. Faglia E, Clerici G, Caminiti M et al. Predictive values of transcutaneous oxygen tension for abovethe-ankle amputation in diabetic patients with critical limb ischemia. Eur J Vasc Endovasc Surg 2007; 33(6): 731–736.

58. Chen X, Fu W, Gu W. Spinal cord stimulation for patients with inoperable chronic critical leg ischemia. World J Emerg Med 2011; 2(4): 262–266.

59. Provenzano DA, Jarzabek G, Georgevich P. The utilization of transcutaneous oxygen pressures to guide decision-making for spinal cord stimulation implantation for inoperable peripheral vascular disease: a report of two cases. Pain Physician 2008; 11(6): 909–916.

60. Gazzaruso C, Coppola A, Falcone C et al. Transcutaneous oxygen tension as a potential predictor of cardiovascular events in type 2 diabetes. Diabetes Care 2013; 36(6): 1720–1725.